Autolomous LTD, a developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of digital enterprise platforms for cell and gene therapy supply chains, have entered a collaboration to integrate Autolomous’ critical manufacturing management systems with Vineti’s Personalized Therapy Management (PTM) platform.   The collaboration aims to enable both parties to create a seamless end-to-end cell and gene therapy (CGT) delivery pathway including critica...